In line with our data, progressively decreased expression of PPARGC1A was shown in lung homogenates of moderate and severe COPD patients (GOLDII and GOLDIII), while increased expression levels were observed in mild COPD patients (GOLDI) compared to control subjects38. This evidence concerns the gene PPARGC1A and chronic obstructive pulmonary disease.